GENESIS BIOTECHNOLOGY GROUP Trademark

Trademark Overview

On Wednesday, April 14, 2010, a trademark application was filed for GENESIS BIOTECHNOLOGY GROUP with the United States Patent and Trademark Office. The USPTO has given the GENESIS BIOTECHNOLOGY GROUP trademark a serial number of 85013546. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, September 14, 2023. This trademark is owned by Medical Diagnostic Laboratories, LLC. The GENESIS BIOTECHNOLOGY GROUP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding waste treatment and the treatment of waste in the marine industry
genesis biotechnology group

General Information

Serial Number85013546
Word MarkGENESIS BIOTECHNOLOGY GROUP
Filing DateWednesday, April 14, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, September 14, 2023
Registration Number4466718
Registration DateTuesday, January 14, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements

Disclaimer with Predetermined Text"BIOTECHNOLOGY GROUP"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding waste treatment and the treatment of waste in the marine industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 19, 2010
Primary Code042
First Use Anywhere DateFriday, December 31, 2010
First Use In Commerce DateSunday, January 30, 2011

Trademark Owner History

Party NameGENESIS BIOTECHNOLOGY GROUP, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
Addresshamilton, NJ 08691
Party NameGENESIS BIOTECHNOLOGY GROUP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NameGENESIS BIOTECHNOLOGY GROUP, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NameMedical Diagnostic Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 14, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, September 14, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, September 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 6, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, January 14, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 1, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, November 1, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, November 1, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 14, 2019TEAS SECTION 8 RECEIVED
Monday, January 14, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 14, 2014REGISTERED-PRINCIPAL REGISTER
Friday, December 13, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 12, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, December 11, 2013ASSIGNED TO LIE
Sunday, December 1, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 6, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 2, 2013USE AMENDMENT FILED
Wednesday, November 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 15, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, April 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 24, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 24, 2012NON-FINAL ACTION E-MAILED
Wednesday, October 24, 2012NON-FINAL ACTION WRITTEN
Monday, October 1, 2012ASSIGNED TO EXAMINER
Saturday, September 8, 2012SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, March 7, 2012REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 6, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 24, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 24, 2011LETTER OF SUSPENSION E-MAILED
Thursday, February 24, 2011SUSPENSION LETTER WRITTEN
Thursday, February 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 3, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 1, 2011ASSIGNED TO LIE
Monday, January 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 4, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 26, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 26, 2010NON-FINAL ACTION E-MAILED
Monday, July 26, 2010NON-FINAL ACTION WRITTEN
Wednesday, July 21, 2010ASSIGNED TO EXAMINER
Monday, April 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 17, 2010NEW APPLICATION ENTERED

Related Keywords

group biotechnology genesis such research disease waste treatment throughput screening compounds chemical discovery